Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03510910 · ClinicalTrials.gov registry record · Phase 4
Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03510910 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 100 participants.
The verdict
NCT03510910, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this proposed study is to evaluate the efficacy of a multimodal approach to analgesia for patient's pain after hip arthroscopy and to also assess if this new approach will result in a reduction in post-operative narcotic use. This study is a single-center, randomized prospective study comparing post-operative pain scores and narcotic consumption between individuals receiving acetaminophen along with a reduced quantity of Percocet (to be used as needed for breakthrough pain) and individuals receiving Percocet only. Both pain management options are considered to be standard of care. Both cohorts will receive aspirin for DVT prophylaxis and celecoxib for heterotopic ossification prophylaxis. The primary objective of the study are to compare patients' narcotic consumption and reported pain following arthroscopic hip surgery, and determine if acetaminophen can provide adequate pain relief compared to a narcotic medication.
Interventions
- DRUG Acetaminophen
- DRUG Percocet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2019-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03510910
The ClinicalTrials.gov registry entry for NCT03510910 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03510910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03510910 about?
NCT03510910 is a clinical study titled "Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy". The purpose of this proposed study is to evaluate the efficacy of a multimodal approach to analgesia for patient's pain after hip arthroscopy and to also assess if this new approach will result in a reduction in post-operative narcotic use. This study is a single-center, randomized prospective stud...
What is the current status of trial NCT03510910?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-04-10. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03510910?
The interventions under investigation include: Acetaminophen (DRUG), Percocet (DRUG).
Who is sponsoring clinical trial NCT03510910?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.